Publications To Date


    Filter Publications

    PAGE 2 OF 155 | DISPLAYING 16 - 30 OF 2318 RESULTS

    Lim J. et. al., Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3, 10.1038/sdata.2018.283, Sci. Data, Dec 11, 2018

    Park D.M. et. al., The UzcRS two‐component system in Caulobacter crescentus integrates regulatory input from diverse auxiliary regulators , 10.1111/mmi.14180, Molecular Microbiology, Dec 08, 2018

    Grabosch S. et. al., Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles,, Oncogene, Dec 05, 2018

    Ryota H. et. al., Clinicopathological and immunological features of follicular pancreatitis—a distinct disease entity characterized by Th17 activation, 10.1111/his.13802, Histopathology, Dec 04, 2018

    Ennishi D. et. al., Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma., 10.1200/JCO.18.01583., J. Clin. Oncol., Dec 03, 2018

    Goschzik T. et. al., Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial, 10.1016/S1470-2045(18)30532-1, Lancet Oncol., Dec 03, 2018

    Freedman J.D. et. al., An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells, 10.1158/0008-5472.CAN-18-1750, Cancer Res., Dec 01, 2018

    Mottok A. et. al., Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens, 10.1182/blood-2018-05-851154 , Blood, Dec 01, 2018

    Lambros L. et. al., NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?, 10.5858/arpa.2018-0251-LE., Arch Pathol Lab Med., Dec 01, 2018

    Hillen L.M. et. al., Molecular profiling of Spitz nevi identified by digital RNA counting., 10.1097/CMR.0000000000000495., Melanoma Res., Dec 01, 2018

    Christmas B.J. et. al., Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs, 10.1158/2326-6066.CIR-18-0070, Can. Immunol. Res., Dec 01, 2018

    Menon D.R. et. al., CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma, 10.1158/0008-5472.CAN-18-0330, Cancer Res., Dec 01, 2018

    Fan K. et. al., Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma, 10.1158/1078-0432.CCR-18-1184, Clin. Can Res., Dec 01, 2018

    Gomes B. et. al., Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy, 10.1158/1535-7163.MCT-17-1104, Mol. Can. Ther., Dec 01, 2018

    Tanaka H. et. al., Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer, 10.1158/1535-7163.MCT-17-1180, Mol. Can. Ther., Dec 01, 2018